High-Resolution Melting Analysis Market expected to grow at a 3.1% CAGR

The report "High Resolution-Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast", report provides a detailed overview of the major drivers, restraints, and threat impacting the high-resolution melting analysis market along with the estimates and forecasts of the revenue and market share analysis.

The Global High-Resolution Melting Analysis Market is expected to reach $302.1 Million, at a CAGR of 3.1% during the forecast period

Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.

Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216456020

On the basis of product & service:

The Market is segmented into instruments, reagents & consumables, and software & services. The reagents and consumables segment dominated the market in 2016; and is expected to continue to dominate the market during the forecast period. The segment is also expected to grow at the highest CAGR during the forecast period.

On the basis of application:

The High-Resolution Melting Analysis Market is broadly classified into SNP genotyping, mutation scanning, species identification, pathogen identification, epigenetics, and other applications. In 2016, the SNP genotyping segment accounted for the largest share of the Market. This can be attributed to the wide range of applications of SNP genotyping in the diagnosis of genetic and autoimmune diseases, study of the variations in drug responses, drug discovery & development, and the identification of genetic variations in plant or animal genomes.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=216456020

On the basis of region:

the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, North America (comprising the U.S. and Canada) accounted for the largest share of the global market, followed by Europe. The rising prevalence of infectious diseases, genetic disorders, & other chronic diseases, and the large number of genotyping-based research and development projects are key growth drivers for the HRM market in North America.

Prominent Key Players in High-Resolution Melting Analysis Market:

Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.).

Viral Clearance Market 2018 Dynamics Set For Rapid Growth and Trend by 2023

According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecast”, published by MarketsandMarkets™.

Revenue Growth of the Market:

The Global Viral Clearance Market is expected to reach $724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7% during the forecast period.

Market Segmentation:-

On the basis of application, the global market is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications. In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules.

On the basis of the method, the viral clearance market is segmented into viral removal and viral inactivation. In 2018, the viral removal segment is expected to account for the largest share of the global market due to the growth in the biopharmaceutical R&D activities; the high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences research

Download PDF (Please provide your specific interest in this report so as to help you better.): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197

Market Growth Drivers:

• Growth in the Pharmaceutical and Biotechnology Industries
• Increasing Number of Drug Launches
• High Incidence and Large Economic Burden of Chronic Diseases
• Possibility of Cell Culture Contamination
• Advancements in Nanofiltration Technology

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197

Geographical Analysis:

The North American region is expected to account for the largest share of the market in 2018.

However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.

Major Key Players In Global Viral Clearance Market:

Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).

Leukapheresis Market Size 2018, Global Industry Analysis,Share, Trends, Status and Future Forecast 2023

The major factors driving the growth of the Leukapheresis Market include the rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes.

The Leukapheresis Products Market is expected to reach USD 27.7 million, at a CAGR of 7.4%

The Leukopaks Market is expected to reach USD 445.6 million, at a CAGR of 46.4% during the forecast period.

Leukapheresis Market Major Drivers;

Increasing incidence and prevalence of leukemia;

Globally, the incidence of leukemia has risen significantly. According to the NIH National Cancer Institute in 2015, 405,815 people were suffering from leukemia in the US. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015). The NIH also estimates that the number of new cases may reach 60,300 in 2018. According to the Leukemia & Lymphoma Society, from 2010 to 2014, leukemia was the sixth-most-common cause of cancer deaths globally.

Browse 134 market data Tables and 49 Figures spread through 194 Pages and in-depth TOC  – Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148

Leukapheresis Market Segmentation:

By product, the apheresis devices segment is expected to account for the largest share of the leukapheresis devices market in 2018

On the basis of type, the leukapheresis devices market is segmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. In 2017, the apheresis devices segment accounted for the largest share of the leukapheresis devices market. The large share of this segment is attributed to the widespread adoption of apheresis devices for performing therapeutic leukapheresis procedures for the treatment of leukemia and development of leukopaks for clinical and preclinical research.

By product, the mobilized PB leukopaks segment is expected to account for the largest share of the leukopaks market in 2018

On the basis of type, the leuopaks market is segmented into mobilized PB leukopaks, non-mobilized PB leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized PB leukopaks segment is expected to account for the largest share of the global leukopaks market in 2018. The dominant share of this segment is attributed to the increasing demand for low-granulocyte and low-hematocrit contamination, high cell viability, and an increase in CD34+ cell frequencies for the development of immunotherapies.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148

Asia Pacific is expected to account for the largest share of the leukapheresis market in 2018, followed by North America. The increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies focusing on cell therapy research are factors are driving the growth of this regional segment.

The prominent players in the global leukapheresis products market are Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics Corporation (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France).

Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).

Global Ureteroscopy Market 2019 Industry Analysis, Size, Share, Growth, Trends and Forecast

The high incidence of urolithiasis across the globe is a major factor driving the growth of this market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible ureteroscopy market in the coming years.

The Research Report on Ureteroscopy Market provides a detailed overview of the major Factors such as the growing incidence of urolithiasis and technological advancements such as single-use ureteroscopes in flexible ureteroscopy are driving the growth of this market.

[101 Pages Report] The global flexible & semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million by 2023 from USD 768.0 million in 2017, at a CAGR of 5.4%.

The Objectives of this Study are as follows:

To define, describe, and forecast the flexible ureteroscopy market by product type, application, end user, and region

To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

To identify the micro-markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market

To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

Download PDF (Semi-rigid Ureteroscopy Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795

Research Methodology:

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by type, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

This research report segments this Ureteroscopy Market based on product type, application, end user, and region

Ureteroscopy Market Segmentation in Detailed:

By product type, the flexible ureteroscopy market is categorized into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share of the global flexible & semi-rigid ureteroscopy market in 2018. Also, technological advancements are allowing hospitals to switch from rigid/semi-rigid ureteroscopes to flexible and fully digital ureteroscopes for improving the accuracy and effectiveness of treatment procedures as well as reducing their overall cost. The flexible ureteroscopes market is further segmented into fiber optic and digital ureteroscopes

Based on application, the flexible & semi-rigid ureteroscopy market is segmented into urolithiasis, urinary stricture, and kidney cancer. Urolithiasis is the largest application segment. Market growth can primarily be attributed to the increasing incidence of kidney stones and the widespread adoption of ureteroscopes in diagnostics.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795

Market Based on Region;

On the basis of region, the flexible & semi-rigid ureteroscopy market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America is expected to command the largest share of the ureteroscopy market.

The large share of this market segment can be attributed to the high prevalence of kidney stones in this region and a large number of surgeries performed each year. However, the high cost of ureteroscopy procedures is expected to restrain the growth of this market during the forecast period.

Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).

Huge Growth Expected for Blood Warmer Devices Market with +8.4% CAGR - By Top Leading Players like 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany)

The Blood Warmer Devices Market is expected to reach USD 225.6 Million by 2022 from USD 150.4 Million in 2017, at a CAGR of 8.4%

Factors driving the growth of this market include the increasing burden of hypothermia cases, increasing number of surgeries, and growing number of trauma cases. According to a report published by Hospital Episode Statistics (HES) and the Health and Social Care Information Centre, the diagnosis rate of hypothermia in the UK increased significantly between 2005 and 2014. This will result in, increasing demand for blood warmer devices/sample warmers during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151850783

The objectives of this study are as follows:

To define, describe, segment, and forecast the blood warmer devices market by sample type, end user, and region

To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market

To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

Blood samples are estimated to account for the largest market share in 2017

By sample type, the Blood Warmer Devices Market is classified into blood samples and other samples. The blood samples segment is expected to lead the global Sample Warmer Devices Market in 2017. Factors driving the growth of this segment include the increasing demand for blood and blood products.

The hospital's segment is expected to dominate the Sample Warmer Devices Market.

By end-user, the market is segmented into hospitals, blood banks & transfusion centers, and tissue banks. The hospital's segment is expected to account for the largest share of the global Blood Warmer Devices Market in 2017. The rising number of blood transfusions and growing requirement of blood in surgical treatments which is a major factor responsible for the dominant share of this segment.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=151850783

North America is estimated to command the largest share of the market

Based on region, the Blood Warmer Devices Market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is expected to dominate the Sample Warmer Devices Market. This is attributed to factors such as the increasing incidence of hypothermia, a growing volume of surgical procedures, and the increasing number of trauma cases of blood warmer devices/sample warmer products in the region as compared to other regions.

Key players in the Blood Warmer Devices Market include 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US).

Global HIP Replacement Devices Market Trends and Industry Analysis Report 2018

According to the new market research report "Hip Reconstruction Devices Market by Product (Primary Hip Reconstruction Devices (Cemented, Cementless), Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast", published by MarketsandMarkets™, is estimated to reach USD 5.9 Billion, at a CAGR of 3.0%

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?
id=76831539

 The government initiative of allocating new funds and development of new policies have reduced the waiting time for hip reconstructions, and increased the number of operations. However, it is difficult to achieve 90% threshold of patients that receive care within the regulated time. The technological advancements in hip reconstruction market, such as newly developed prostheses with improved strength and reliability of joints are reducing the need and cost of revision surgery. The minimally invasive techniques for hip reconstruction surgery will improve the precision and accuracy of surgeons, thus reducing the time of surgery. The emergence of these techniques and other improved surgical tools for the treatment of arthritis is expected to address the rising demand for surgery during the forecast period.

Browse and in-depth TOC on "Hip Reconstruction Devices Market" 
105 - Tables
114 -  Figures 
228 - Pages 

In 2014, the global hip reconstruction devices market was dominated by North America. This market is segmented and forecast on the basis of product, and geography. The product comprises of primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices.

The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, and Asia-Pacific. These major geographies are further sub-segmented into major countries.

The market in North America is growing due to rising pool of arthritis, and favorable reimbursement. The European market is growing due to the technological advancements and is dominated majorly by Zimmer Inc. (U.S.) and Depuy Synthes (U.S.). The Asian market is growing due to growing health awareness among masses, along with increase in the spending capacity of the Indian population. Also, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and rising awareness towards hip reconstruction are propelling the market growth. 

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=76831539

The research study is aimed at identifying emerging trends and opportunities in the global hip reconstruction devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hip reconstruction devices market, on the basis of product, and region.

Global Medical Automation Market 2019: Industry Analysis, Size, Share, Revenue and Forecast

The Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the market. However, high cost of automation is one of the key restraints for this market.

According to the new market research report "Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast", published by MarketsandMarkets™.

Revenue Growth Opportunities:

Medical Automation Market is projected to reach USD 55.03 Billion, at CAGR of 9.5%

Market Segmentation in-Detailed:-

On the basis of application, the market is divided into four major segments, namely, diagnostic and monitoring automation (automated imaging, automated image analysis, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistics automation and trainers).

The therapeutic automation segment is estimated to hold the largest share of the global medical automation market. Increasing application of automated devices (such as defibrillators, surgical robots, surgical navigation systems, and automated medication systems) in therapeutics and rising incidences of various chronic diseases are driving the growth of this market segment.

On the basis of end users, the global market is divided into four segments, namely, hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=848

Worldwide Geographical Segmentation in-detailed:

The Medical Automation therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is estimated to hold the largest share of the global market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 11.6% from 2015 to 2020. Presence of a large geriatric population; increasing prevalence of CVDs, diabetes, and cancer; rising number of clinical research activities; and growing government expenditure on healthcare and life sciences research are propelling the growth of the Asia-Pacific market.

Emerging Asia-Pacific countries, including India and China, offer high growth potential for companies engaged in the development and marketing of automated solutions for the healthcare industry.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=848

Leading Key Players in the Worldwide Industry:

The major players operating in the Medical Automation Market are Koninklijke Philips N.V. (Netherlands), Siemens AG, (Germany), General Electric Company (U.S.), Medtronic plc. (U.S.), Tecan Group Ltd. (Switzerland), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland)

Biobanking Market Forecast 2024, opportunities with Huge Profit and Marginal Revenue

Biobanking Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the market.

The availability of government funding for regenerative medicine, stem cell therapeutics, and cell & gene therapy is supporting research activities in this segment. Apart from this, the increasing trend of cord blood banking will also aid the growth of this market segment. Prospects including advancements in orthopedic procedures with the use of stem cells are expected to further support market growth for regenerative medicine.

Worldwide Growth Opportunities in Terms of Revenue & Segmentation:

The Biobanking Market is expected to reach $2.69 billion, Nearly at a CAGR of 7.8%. 

The Global market is segmented by product and service, sample type, storage type, application and regions.

By product and service, the market is segmented into equipment, consumables, services and software. The equipment segment is expected to lead the global market. Factors such as the growth in the number of biobanks and the number of biosamples to be stored are increasing the demand for biobanking devices market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

By sample type, the Biobanking Market is classified into blood products, human tissues, cell lines, nucleic acids, human waste products, and biological fluids. Since blood and blood products are the most collected specimens and are used as a source of DNA and RNA, this segment type holds the largest share of the biobanking devices market.

On the basis of applications, the market is segmented into regenerative medicine, life science research, and clinical research. Regenerative Medicine is expected to account for the largest share of the market based on applications. Growing research in regenerative medicine and the increasing demand for well-characterized and quality biosamples for research are prime reasons for the growth of this market segment.

Global Geographical Analysis for Biobanking Market:

The Global market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Improving life sciences research infrastructure in emerging economies and growing government investment in biomedical, pharmaceutical, and biotechnology industries are some of the factors propelling market growth in the Asia-Pacific region.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=594

The Major Factors Driving the Growth of Biobanking Market:

·         Increase in Genomic Research Activities for Studying Diseases

·         Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns

·         Government and Private Funding to Support Regenerative Medicine Research

·         Growing Need for Cost-Effective Drug Discovery and Development

Major Key Players in Global Biobanking Market:

Key players in the market includes Hamilton Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Brooks Automation (U.S.), and Panasonic Healthcare Holdings Co. Ltd (Japan) have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.